CClinicalTrials.gg
CompletedNCT01663181Updated Apr 12, 2022

Pain-perception During Outpatient cystoscopy-a Prospective Controlled Study

An observational study in Urinary Incontinence, Overactive Bladder and Pelvic Organ Prolapse, sponsored by Medical University of Vienna. Completed at 1 site in Austria. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-04-12.

Sponsored by Medical University of Vienna · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
109
Ages
18 Years and older
Sex
Female
01

Study summary

At an academic tertiary referral center, patients with pelvic floor dysfunction, scheduled for outpatient cystoscopy or urodynamic testing will be asked to participate in the study. Patients will be called one day after the examination and will be asked about pain and their general state of health.

The purpose of this study it to investigate pain perception in urogynecologic patients during outpatient cystoscopy and compare it with pain perception during outpatient urodynamic. The investigators will also investigate the difference between anticipated and actual pain perception. The investigators will test the null hypothesis that there is no difference in patients´ pain perception between outpatient cystoscopy and urodynamic testing. The secondary hypothesis will be that there is no difference between patients´ anticipated amount of pain and the actually experienced pain during cystoscopy and urodynamic testing.

According to power calculation, a sample size of 52 patients per group will be needed to detect a 2 cm difference in pain scores on the VAS - judged as a clinically significant difference - with 95% power and a two-sided significance level of 0.05.

Exclusion criteria are: age ≤ 18 years, insufficient ability to understand German, pregnancy and the participation in another clinical study at the same time.

02

Conditions studied

  • Urinary Incontinence
  • Overactive Bladder
  • Pelvic Organ Prolapse
  • Recurrent Urinary Tract Infections
03

In context

Urinary Tract Infections

753 studies on the registry are indexed under Urinary Tract Infections; 128 are open to participants now.

This study's enrollment of 109 is below the median of 200 across 188 observational studies indexed under Urinary Tract Infections.

Browse Urinary Tract Infections studies →

Lead sponsor

Medical University of Vienna is the lead sponsor of 1,076 studies on the registry; 177 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

women, aged >= 18 years with pelvic floor dysfunction, undergoing diagnostic work-up at a tertiary referral center for urogynecologic conditions

Inclusion criteria

  • women undergoing cystoscopy or urodynamic testing at an academic tertiary referral center.

Exclusion criteria

Exclusion Criteria:

  • age ≤ 18 years
  • insufficient ability to understand German
  • pregnancy
  • participation in another clinical study at the same time
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
109 participants (actual)

Groups and cohorts

  • urogynecologic patients undergoing outpatient cystoscopy
  • urogynecologic patients undergoing outpatient-urodynamics
06

What researchers measure

Primary outcomes

  1. subjective pain perception immediately after examination as measured by a standard visual analog scale

    patients are assessed at three points in time: 1. zero to ten minutes before undergoing examination 2. zero to ten minutes after undergoing examination 3. 24 hours after undergoing examination

    Time frame: immediately after examination (zero to ten minutes after completing cystoscopy or urodynamics)

Secondary outcomes

  1. difference between anticipated pain and actual pain perception

    Time frame: immediately before and immediately after the examination (zero to ten minutes after undergoing examination)

07

Study locations

1 site
  • Medical University Vienna
    Vienna, 1090, Austria
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 12, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01663181
Lead sponsor
Medical University of Vienna
Responsible party
Wolfgang Umek, MD (ao.Univ.Prof.Dr.univ.med, Medical University of Vienna) — Principal investigator
First posted
Aug 13, 2012
Start date
May 2009
Primary completion
Feb 2010
Completion
Apr 2010
Last update
Apr 12, 2022

Study contacts

Wolfgang Umek, Prof
principal investigator · Medical University Vienna Austria

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion